Background: Antibodies to soluble liver antigen (SLA)/liver pancreas (LP) are generally considered as highly specific diagnostic markers of type 1 auto‐immune hepatitis (AIH‐1), and are particularly useful in patients without conventional antibodies. However, the presence of anti‐SLA/LP in type 2…